格隆汇10月9日丨ST联创(300343.SZ)公布，截至2025年9月30日，公司通过回购专用证券账户，以集中 竞价交易方式累计回购公司股份12,104,900股，占目前公司总股本的1.13%，最高成交价为4.28元/股， 最低成交价为3.93元/股，成交总金额为50,194,917.00元（不含交易费用）。本次回购符合相关法律法规 和公司既定的回购股份方案的要求。 ...

证券代码：300343 证券简称：ST联创 公告编号：2025-053 山东联创产业发展集团股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 公司于 2025 年 3 月 19 日收到山东监管局下发的《行政处罚事先告知书》， 根据《事先告知书》认定的情况，公司涉及的违法违规行为触及《深圳证券交易 所创业板股票上市规则（2024 年修订）》第 9.4 条第一款第（七）项规定的被 实施其他风险警示情形，公司股票于 2025 年 3 月 25 日起被实施其他风险警示， 具体内容详见公司在巨潮资讯网上披露的《关于公司股票被实施其他风险警示暨 停复牌的公告》（公告编号：2025-006）。 二、采取的措施及进展情况 1、公司收到《事先告知书》后立即采取行动，组织财务等各相关部门以及 年审会计师事务所工作人员就《事先告知书》涉及的情况进行仔细梳理、研判并 开始内部整改工作。针对相应财务报表的差错更正及追溯调整工作尚在有序开展 中。公司将尽快对相应年度的财务信息进行追溯重述，会计师事务所届时将对此 出具专项 ...

证券代码：300343 证券简称：ST联创 公告编号：2025-054 山东联创产业发展集团股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 山东联创产业发展集团股份有限公司（以下简称"公司"）于 2025 年 4 月 8 日召 开第四届董事会第二十三次会议，审议通过《关于回购公司股份方案的议案》，同意公 司以自有资金通过集中竞价交易方式回购部分公司发行的人民币普通股（A 股）。本次 回购的资金总额不低于人民币 5,000 万元（含）且不超过人民币 10,000 万元（含）， 回购价格不超过人民币 8.00 元/股，实施期限自公司董事会审议通过最终回购股份方案 之日起不超过 12 个月。具体内容详见公司于 2025 年 4 月 8 日在巨潮资讯网 （www.cninfo.com.cn）披露的《关于回购公司股份方案的公告》（公告编号：2025-009）。 2、公司以集中竞价交易方式回购股份符合下列要求： （1）委托价格不得为公司股票当日交易涨幅限制的价格； （2）不得在深圳证券交易所开盘集合竞价、收盘集合竞价及股票价格无涨跌幅限 ...

Core Viewpoint - The company is currently under other risk warnings and is working towards applying for the removal of these warnings after meeting specific conditions set by the Shenzhen Stock Exchange [1] Group 1 - The company can apply for the removal of the risk warning after fulfilling two conditions: (1) the company must restate its financial reports for the relevant years concerning the administrative penalty, and (2) at least twelve months must have passed since the China Securities Regulatory Commission issued the administrative penalty decision [1] - The company has already initiated actions upon receiving the administrative penalty notice, involving relevant departments and auditors to address the issues mentioned in the notice [1] - The correction and retrospective adjustment of the financial statements are currently in progress, and the company aims to restate the financial information as soon as possible [1]

Market Overview - The Shanghai Composite Index closed at 3877.55 points, with a change of 0.41% [1] - The total trading volume of A-shares reached 1561.918 billion yuan [1] Technical Analysis - A total of 127 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - COFCO Technology: 5-day MA at 11.41 yuan, 10-day MA at 11.52 yuan, difference of -0.92% [1] - Jiuri New Materials: 5-day MA at 27.35 yuan, 10-day MA at 27.59 yuan, difference of -0.86% [1] - Potential Energy Trust: 5-day MA at 20.44 yuan, 10-day MA at 20.59 yuan, difference of -0.77% [1] Individual Stock Performance - COFCO Technology: Today's change of 0.09%, trading volume of 1.13% [1] - Jiuri New Materials: Today's change of 1.49%, trading volume of 1.84% [1] - Potential Energy Trust: Today's change of 0.34%, trading volume of 1.64% [1] - Other notable stocks with death crosses include: - Tongzhou Electronics: Today's change of -0.42%, trading volume of 2.40% [1] - ST Long Pharmaceutical: Today's change of -2.50%, trading volume of 2.14% [1] - Jin Hong Shun: Today's change of -1.44%, trading volume of 2.07% [1]

证券代码：300343 证券简称：ST联创 公告编号：2025-052 山东联创产业发展集团股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 山东联创产业发展集团股份有限公司（以下简称"公司"）于 2025 年 4 月 8 日召 开第四届董事会第二十三次会议，审议通过《关于回购公司股份方案的议案》，同意公 司以自有资金通过集中竞价交易方式回购部分公司发行的人民币普通股（A 股）。本次 回购的资金总额不低于人民币 5,000 万元（含）且不超过人民币 10,000 万元（含）， 回购价格不超过人民币 8.00 元/股，实施期限自公司董事会审议通过最终回购股份方案 之日起不超过 12 个月。具体内容详见公司于 2025 年 4 月 8 日在巨潮资讯网 （www.cninfo.com.cn）披露的《关于回购公司股份方案的公告》（公告编号：2025-009）。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号 ——回购股份》的有关规定，回购期间，公司应当在每个月的前三个交易日内披露截至 上月末的回购进展情况。 ...

证券代码：300343 证券简称：ST联创 公告编号：2025-051 山东联创产业发展集团股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 三、对公司的影响及风险提示 1、截至本公告披露日，公司生产经营正常。公司将持续关注触及其他风险 警示相关事项进展，并根据《深圳证券交易所创业板股票上市规则（2024 年修 订）》第 9.9 条的规定每月披露一次进展公告，直至披露财务会计报告更正公告 及会计师事务所出具的专项核查意见等文件。 2、公司将继续严格按照有关法律法规的规定和要求，认真履行信息披露义 务，及时做好信息披露工作。公司指定的信息披露媒体为巨潮资讯网 （www.cninfo.com.cn）、《中国证券报》、《证券日报》、《证券时报》、《上 海证券报》，有关公司所有信息均以在上述指定媒体刊登的信息为准，敬请广大 投资者理性投资，注意风险！ 2、根据《深圳证券交易所创业板股票上市规则（2024 年修订）》第 9.9 条 规定，公司因触及第 9.4 条第七项情形，其股票交易被实施其他风险警示期间， 应当至 ...

Financial Performance - The company achieved operating revenue of 443.21 million yuan, representing a year-on-year increase of 12.83% [2][3] - The net profit attributable to shareholders was 11.70 million yuan, a significant turnaround from a loss of 12.72 million yuan in the same period last year, marking a 191.96% improvement [2][3] - The net profit after deducting non-recurring gains and losses was 4.31 million yuan, compared to a loss of 19.66 million yuan in the previous year, reflecting a 121.91% increase [2][3] - The basic earnings per share were 0.011 yuan, a recovery from a loss of 0.0115 yuan per share in the previous year, indicating a 195.65% improvement [2][3] - The net cash flow from operating activities was 15.92 million yuan, a substantial increase of 186.74% from a negative cash flow of 18.36 million yuan last year [2][3] Assets and Equity - Total assets at the end of the reporting period were 2.50 billion yuan, a decrease of 1.91% from the previous year-end [3] - The net assets attributable to shareholders were 1.92 billion yuan, down from 1.96 billion yuan at the end of the previous year [3] Innovation and Recognition - The company holds 103 valid patents, with three patents awarded prestigious national and industry-level honors [4] - The company has been recognized as one of the top 10 listed companies in China's fluorochemical industry and has received multiple awards for innovation and technology [4] - The company has established several research and development centers and is recognized as an industrialization base by the China Weapon Industry Group [4] - The company is a domestic manufacturer with independent intellectual property rights for fourth-generation refrigerants and foaming agents, and is advancing the production processes for high-end fluorochemical products [4]

Core Insights - ST Lianchuang (300343.SZ) reported a total operating revenue of 443 million yuan for the first half of 2025, an increase of 50.39 million yuan or 12.83% compared to the same period last year [1] - The net profit attributable to shareholders reached 11.70 million yuan, an increase of 24.42 million yuan compared to the same period last year [1] - The net cash inflow from operating activities was 15.92 million yuan, an increase of 34.28 million yuan year-on-year [1] Financial Ratios - The latest debt-to-asset ratio stands at 18.83%, a decrease of 2.80 percentage points from the same period last year [3] - The gross profit margin is reported at 13.50%, an increase of 4.78 percentage points year-on-year [3] - The return on equity (ROE) is 0.61%, an increase of 1.27 percentage points compared to the same period last year [3] Earnings and Turnover - The diluted earnings per share are 0.01 yuan, an increase of 0.02 yuan from the same period last year [4] - The total asset turnover ratio is 0.18 times, an increase of 0.04 times or 26.24% year-on-year [4] - The inventory turnover ratio is 2.29 times, an increase of 0.02 times, marking two consecutive years of growth, with a year-on-year increase of 0.81% [4] Shareholder Information - The number of shareholders is 66,300, with the top ten shareholders holding a total of 174 million shares, accounting for 16.29% of the total share capital [4] - The largest shareholder, Li Hongguo, holds 12.14% of the shares [4]

Core Viewpoint - ST Lianchuang (300343) reported a significant improvement in financial performance for the first half of 2025, with notable increases in revenue and net profit compared to the same period in 2024 [1] Financial Performance Summary - Total revenue for the first half of 2025 reached 443 million yuan, a year-on-year increase of 12.83% [1] - The net profit attributable to shareholders was 11.7 million yuan, up 191.96% from a loss of 12.7 million yuan in the same period last year [1] - In Q2 2025, total revenue was 283 million yuan, reflecting a 13.19% increase year-on-year, while net profit was 6.68 million yuan, up 135.99% [1] - Gross margin improved to 13.5%, a year-on-year increase of 54.76%, and net margin reached 3.0%, up 194.09% [1] Key Financial Metrics - Operating expenses (sales, management, and financial expenses) totaled 35.79 million yuan, accounting for 8.07% of revenue, a slight increase of 1.64% year-on-year [1] - Earnings per share (EPS) improved to 0.01 yuan, a 195.65% increase from a loss of 0.01 yuan in the previous year [1] - Operating cash flow per share was 0.01 yuan, up 186.74% from a loss of 0.02 yuan [1] Asset and Liability Overview - Cash and cash equivalents decreased by 30.54% to 220 million yuan [1] - Accounts receivable increased by 27.88% to 135 million yuan, with accounts receivable to profit ratio reaching 616.54% [2] - Interest-bearing debt decreased by 56.00% to 56.11 million yuan [1] Business Model and Historical Performance - The company's return on invested capital (ROIC) was 0.9%, indicating weak capital returns, with a historical median ROIC of 1.88% over the past decade [1] - The company has reported losses in three of the twelve annual reports since its listing, suggesting a fragile business model [1] - The company's performance is primarily driven by research and marketing efforts, necessitating further investigation into these drivers [1]